News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


New treatment funded for severe gout

New treatment funded for severe gout

Patients with severe gout will soon have a new treatment option as PHARMAC will be funding febuxostat (Adenuric) from 1 June 2014.

Gout is a painful form of arthritis, and is associated with high levels of uric acid in the blood. Pharmaceutical gout treatments aim to reduce the level of uric acid in the blood and relieve
the symptoms of gout. Gout affects men more than women and is more prevalent among Māori and Pacific people.

PHARMAC’s Director of Operations Sarah Fitt says several pharmaceutical gout treatments are already funded, including allopurinol and probenecid. PHARMAC funded a further treatment
for severe gout last year, benzbromarone, although it is an unregistered medicine in New Zealand.

“Our clinical advisory committees have identified a need for additional treatments for severe gout, so it is pleasing to be able to fund febuxostat,” says Sarah Fitt. “While most patients are
treated effectively with the currently available treatments, this will offer further relief for patients with gout that is more difficult to treat.”

PHARMAC expects funding for febuxostat to account for about $5 million in spending over the next five years.

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Northland Development: Trust Applauds $4m Government Funding For Art Centre

Today's announcement of central government support, made by Minister of Economic Development Steven Joyce, provides a key step forward in funding for Whangarei’s Hundertwasser Art Centre & Wairau Maori Art Gallery. More>>

ALSO:

Memorial: 85th Anniversary Of 1931 Napier Earthquake

Civil Defence Minister Nikki Kaye will today attend the 85th anniversary afternoon tea for survivors of the 1931 Napier earthquake, to pay tribute to the heroism, kindness and generosity shown by many during this and more recent emergencies. More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news